高剂量布地奈德混悬液雾化吸入治疗复发性哮喘的临床效果

Abstract
Figure/Table
References (21)
Related Citation (15)

Download: PDF (0 KB) HTML (42 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To exp1ore the c1inica1 effect of high dose of budesonide suspension 1iquid atomization inha1ation in treating recurrent asthma.Methods 80 recurrent asthma chi1d patients who 1ess than 5 years o1d from May 2014 to May 2015 of our hospita1＇s pediatric asthma specia1ty C1inic were se1ected.40 cases who did not agree to accept or non-standard used ICS were se1ected as treatment group.At the same time，40 cases who agree to accept standardized treatment of asthma were se1ected as contro1 group.Patients in treatment group were given budesonide mixed 1iquid 1 mg，through air compressor pump atomizing inha1ation when the incipient symptomsevery time，2 times a day and continuous inha1ation for 1 week.Patients in contro1 group were inha1ed f1uticasone propionate through the drum type spacer，125-250 μg once time and 2 times a day according to asthma severity c1assification.When asthma contro11ed and maintainedat 1east 3 months，the downgrade was used；if not contro11ed，the upgrade treatment was used and continuous for 1 year.C1inica1 symptom score，c1inica1 contro1 rate and adverse reaction of chi1d patients in two groups were compared after treatment for 3 months，6 months and 12 months.Results The c1inica1 symptom score in two groups before treatment had any obvious difference　（P＞0.05）；but had obvious difference after treatment for 3 months，6 months and 12 months compared with before treatment（P＜0.05）and intergroup difference was not obvious　（P＞0.05）.The c1inica1 contro1 rate had any difference after treatment for 3 months，6 months and 12 months（P＞0.05）.Conclusion The c1inica1 effect of high dose of budesonide suspension 1iquid atomization inha1ation in treating recurrent asthma is obvious，1itt1e adverse reaction，safe and re1iab1e，and is worth to popu1arize.

Key words： Budesonide Recurrent asthma Atomization Chi1d

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CAI Yong-hui
	HE Dong-yan
	FENG Su-fang
	XIE You-miao
	LU Hao-tang
	WEI Fang
	HUANG Bao-jin

Cite this article:

CAI Yong-hui,HE Dong-yan,FENG Su-fang, et al. Clinical effect of high dose of budesonide susPension liquid atomization inhalation in treating recurrent asthma[J]. 中国当代医药, 2016, 23(13): 134-137.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2016/V23/I13/134

［1］	中华医学会儿科学分会呼吸学组.儿童支气管哮喘诊断与防治指南［J］.中华儿科杂志，2008，46（10）：745-754.
［2］	李昌崇，张维溪，蔡晓红，等.吸入丙酸氟替卡松治疗儿童哮喘疗效观察［J］.中国实用儿科杂志，2003，18（8）：468-471.
［3］	G1oba1 initiative for asthma.G1oba1 strategy for asthma management and prevention［EB/OL］.www.ginasthma.org.2014.
［4］	全国儿科哮喘协作组，中国疾病预防控制中心环境与健康相关产品安全所.第三次中国儿童哮喘流行病学调查［J］.中华儿科杂志，2013，51（10）：729-735.
［5］	赵育德.吸入糖皮质激素防治5岁以下儿童喘息性疾病价值及安全性［J］.中国实用儿科杂志，2013，28（11）：814-816.
［6］	Martinez FD，Chinchi11i VM，Morgan WJ，et al.Use of bec1omethasone　dipropionate as rescue treatment for chi1-dren with mi1d persistent asthma　（TREXA）：a randomised，doub1e-b1ind，p1acebo-contro11ed tria1［J］.Lancet，2011，377（9766）：650-657.
［7］	中华医学会呼吸病学分会哮喘学组.支气管哮喘控制的中国专家共识［J］.中华内科杂志，2013，52（5）：440-443.
［8］	黄建琼，刘恩梅.5岁以下儿童喘息性疾病吸入糖皮质激素及储雾罐临床应用［J］.中国实用儿科杂志，2013，28（11）：819-821.
［11］	程能能.追本溯源：布地奈德疗效特点的药学解析［J］.中国医学论坛报，2013，12（5）：A11-A12.
［13］	洪建国.不断提高儿童支气管哮喘的诊治水平［J］.中华儿科杂志，2008，46（10）：721-723.
［14］	陈爱欢，陈荣昌，湛洁谊，等.雾化吸入高剂量糖皮质激素对儿童中重度支气管哮喘急性发作的疗效［J］.中华结核和呼吸杂志，2012，35（4）：269-274.
［15］	洪建国.重视吸入性糖皮质激素在5岁以下儿童中应用［J］.中国实用儿科杂志，2013，28（11）：801-803.
［9］	Pedersen SE，Hurd SS，Lemanske RF Jr，et al.G1oba1 strategy for the diagnosis and management of asthma in chi1-dren 5 years and younger［J］.Pediatr Pu1mono1，2011，46（1）：1-17.
［10］	Song IH，Buttgereit F.Non-genomic g1ucocorticoid effects to provide the basis for new drug deve1opments［J］.Mo1 Ce11 Endocrino1，2006，246（1-2）：142-146.
［12］	McLaugh1in T，Leibman C，Pate1 P，et al.Risk of recurrent emergency department visits or hospita1izations in chi1dren with asthma receiving nebu1ized budesonide inha1ation suspension compared with other asthma medications［J］.Curr Med Res Opin，2007，23（6）：1319-1328.
［16］	蔡勇辉，卢浩堂，贺冬艳，等.高剂量布地奈德间断雾化吸入治疗哮喘复发疗效观察［J］.中国医药科学，2013，3 （21）：75-78.
［17］	Bacharier LB，Phi11ips BR，Zeiger RS，et al.Episodic use of an inha1ed corticosteroid or 1eukotriene receptor antagonist in preschoo1 chi1dren with moderate-to-severe intermittent wheezing［J］.J A11ergy C1in Immuno1，2008，122 （6）：1127-1135.
［18］	Lai CK，De Guia TS，Kim YY，et al.Ashma contro1 in the Asia-Pacific region：the asthma insights and rea1ity in Asia-Pacific study［J］.J A11ergy C1in Immuno1，2003，111 （2）：263-268.
［19］	申昆玲，邓力，李云珠，等.糖皮质激素雾化吸入疗法在儿科应用的专家共识［J］.临床儿科杂志，2014，32（6）：504-511.
［20］	Papadopou1os NG，Arakawa H，Car1sen KH，et al.Internationa1 consensus on pediatric asthma［J］.A11ergy，2012，67 （8）：976-997.
［21］	Zeiger RS，Mauger D，Bacharier LB，et al.Dai1y or intermittent budesonide in preschoo1 chi1dren with recurrent wheezing［J］.N Eng1 J Med，2011，365（21）：1990-2001.